Binding of cryptococcal polysaccharide to Cryptococcus neoformans
about
The outcome of phagocytic cell division with infectious cargo depends on single phagosome formationPbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly.Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrationsThe capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibodyCytotoxic T lymphocyte antigen costimulation influences T-cell activation in response to Cryptococcus neoformans.Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin.A yeast under cover: the capsule of Cryptococcus neoformans.Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytesAdherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsuleCapsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.Capsulelike surface material of Mycoplasma dispar induced by in vitro growth in culture with bovine cells is antigenically related to similar structures expressed in vivo.Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans.Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype ABinding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharideProduction and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.The capsule of the fungal pathogen Cryptococcus neoformans.Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding.Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans.Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans.Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans.Unraveling the biology of a fungal meningitis pathogen using chemical genetics.Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rbeta2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells.
P2860
Q27300249-D609BA05-A96C-4A4A-BF67-AE2D235FEF3CQ33766799-5D5BCB3A-A7A6-46BB-B136-9700C1C7A7E4Q33975989-89BD3E7E-92A5-43D3-A952-AAF627BCAF36Q34001769-0285D3CE-72E2-46AB-B35F-010FC9FBE255Q34006313-A3925681-6BD9-437F-8074-144683E1C4F1Q34125581-F9078DB1-8195-4A5F-884A-A72181927B7CQ34236760-72106F9E-292E-4988-A19D-2ACE8173C4BEQ35197202-1A65F539-BD54-43B2-99FC-941431F7B87CQ35427625-328D573C-1D13-4E2F-956B-57F8B3699CB1Q35449775-0FA1427F-11EB-44CE-8912-9DF48DEF96E7Q35508763-94D833C1-0221-4D0B-BD04-1774AFC9FA88Q36967898-DA7CB0A1-4BB0-48DB-8CEC-13640F8185CDQ36999560-7279298C-842E-4233-99F8-8238E7943B94Q37006902-2EDAF03F-CAB2-4BBB-B7A8-B6D3CD7F1F1DQ37013969-61CFB20D-92C4-4E9A-8390-F828ED684F13Q37017345-4BF56B94-8640-4977-8056-1C3B02A60446Q37021882-328070DA-8D53-421E-8376-38111CEFA191Q37337879-49C0B22A-76D6-4E09-B139-6D7D952926F8Q39569976-FB1485AA-0689-4AC9-8964-6530BDD84B94Q39829782-06398BA7-1275-4D11-9A27-4488315B1040Q40267867-0FE7C999-1DAD-418D-8955-BA551D396227Q40373891-03C30B1E-1A72-4CDA-A255-BEBEFCBB1A73Q41096721-FDF1C141-A551-4916-8805-78A140BCD1B9Q41652452-819B9A68-BF9B-476D-A99D-C4E7156F7345Q44016595-502D484F-3DA4-4A18-8801-5D5C2B192E6D
P2860
Binding of cryptococcal polysaccharide to Cryptococcus neoformans
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1984
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Binding of cryptococcal polysaccharide to Cryptococcus neoformans
@en
Binding of cryptococcal polysaccharide to Cryptococcus neoformans.
@nl
type
label
Binding of cryptococcal polysaccharide to Cryptococcus neoformans
@en
Binding of cryptococcal polysaccharide to Cryptococcus neoformans.
@nl
prefLabel
Binding of cryptococcal polysaccharide to Cryptococcus neoformans
@en
Binding of cryptococcal polysaccharide to Cryptococcus neoformans.
@nl
P2860
P1476
Binding of cryptococcal polysaccharide to Cryptococcus neoformans
@en
P2860
P304
P407
P577
1984-03-01T00:00:00Z